Physician profile
William Schafranek
NPI 1982815635
$9,547.36
in general payments reported to CMS, 2019-2025
48 companies · $972 in 2025
The $972 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,245 · 2020: $428 · 2021: $854 · 2022: $2,008 · 2023: $1,451 · 2024: $1,589 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,012.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,670.90 | 2021-2025 | Onyx Frontier, Symplicity G3, Telescope |
| Astrazeneca Pharmaceuticals LP | $973.84 | 2019-2025 | Wainua, Farxiga |
| Janssen Pharmaceuticals, INC | $894.06 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $836.78 | 2019-2023 | |
| Abbott Laboratories | $608.29 | 2019-2025 | Esprit, Absolute Pro, Mitraclip |
| Edwards Lifesciences Corporation | $565.58 | 2019-2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $442.05 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $416.65 | 2019-2020 | |
| Boston Scientific Corporation | $347.68 | 2019-2024 | Bodyguardian, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.11 | 2019-2025 | Lifevest |
| Abiomed | $233.14 | 2019-2025 | |
| Shockwave Medical, INC | $225.24 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $198.89 | 2022-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $192.01 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $188.53 | 2020-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $179.77 | 2022-2024 | (Bh4) Igt Devices Undivided |
| Daiichi Sankyo INC. | $138.33 | 2019-2023 | Injectafer |
| Merck Sharp & Dohme LLC | $119.71 | 2021-2023 | Verquvo |
| Cardiva Medical, INC. | $102.88 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $75.72 | 2022 | |
| Cleerly, INC. | $70.51 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Pfizer INC. | $62.88 | 2019-2022 | |
| Inspire Medical Systems, INC. | $56.36 | 2023-2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $55.96 | 2019-2025 | Evkeeza |
| Kowa Pharmaceuticals America, INC. | $52.21 | 2019-2021 | |
| Esperion Therapeutics, INC. | $51.32 | 2020-2022 | |
| Atricure, INC. | $45.13 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Sanofi-Aventis U.S. LLC | $42.44 | 2019-2023 | |
| Baxter Healthcare | $41.93 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Penumbra, INC. | $39.39 | 2021-2023 | Indigo System |
| Terumo Medical Corporation | $36.88 | 2023 | Glidesheath Slender |
| Endologix LLC | $35.04 | 2024 | Torus Stent Graft System, Endocross Device |
| Novo Nordisk INC | $34.21 | 2023-2024 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals International, Plc | $31.79 | 2024 | Arcalyst |
| Heartflow, INC. | $31.25 | 2024 | |
| United Therapeutics Corporation | $29.80 | 2022-2023 | Tyvaso |
| Cordis US Corp. | $27.96 | 2022 | |
| Cvrx, INC. | $18.46 | 2024 | Barostim Neo System |
| Angiodynamics, INC. | $17.17 | 2024 | Auryon Laser System 100-120 Vac |
| Janssen Biotech, INC. | $17.11 | 2023 | Xarelto |
| Azurity Pharmaceuticals, INC. | $16.88 | 2024 | Edarbyclor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.79 | 2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $15.48 | 2023 | Inpefa |
| Medicomp INC | $14.33 | 2024 | Telepatch Cardiac Monitor |
| Arbor Pharmaceuticals, INC. | $13.71 | 2019 | |
| Altathera Pharmaceuticals LLC | $13.03 | 2025 | Sotalol Hydrochloride |
| Vifor Pharma, INC. | $12.18 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Schafranek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.